ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 1231 • ACR Convergence 2025

    TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, Demonstrates Pain Reduction and Favorable Tolerability in Patients with Fibromyalgia

    Gregory Sullivan1, Errol Gould2, Mary Kelley1, Jean Engels1 and Seth Lederman3, 1Tonix Pharmaceuticals, Inc., Chatham, NJ, 2Tonix Pharmaceutical, Inc., Henderson, NV, 3Tonix Pharmaceuticals, Inc., Austin, TX

    Background/Purpose: FDA-approved treatments for fibromyalgia (FM) have historically been limited by intolerable side effects that often lead to poor adherence. TNX-102 SL, a sublingual formulation…
  • Abstract Number: 1228 • ACR Convergence 2025

    Transcending barriers to pain care in rural America: a pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain

    Brennan Spiegel1, Jeffrey Curtis2, Yashar Eshraghi3, Maged Guirguis3, Beth Darnall4, Christine Rini5, Emily Holladay6, Mehra Muskaan1, So Yung Choi1 and Samuel Eberlein1, 1Cedars Sinai, Los Angeles, CA, 2Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, 3University of Queensland Ochsner Medical School, New Orleans, LA, 4Stanford University School of Medicine, Palo Alto, CA, 5Northwestern University, Chicago, IL, 6University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Evidence-based behavioral treatments for chronic pain are largely inaccessible, particularly to rural patients. This decentralized randomized controlled trial compared the effectiveness of two digital,…
  • Abstract Number: 2437 • ACR Convergence 2025

    Bupropion for Lupus-Induced Fatigue Treatment (B-LIFT): A Retrospective Analysis

    Aaron Smith1, Thuyvan Phan2, Leah Luizza3, Anthony Trujillo3, Becki Cleveland1, Shruti Saxena Beem4, Tessa Englund5, Claire Timon4 and Saira Sheikh5, 1University of North Carolina, Chapel Hill, NC, 2UNC Health, Chapel Hill, NC, 3University of North Carolina, Chapel Hill, 4University of North Carolina at Chapel Hill, Chapel Hill, 5University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multi-system autoimmune disease with heterogenous presentation. Most patients with SLE report fatigue or brain fog, which often…
  • Abstract Number: 1226 • ACR Convergence 2025

    Preliminary Findings in the Validation of the Modified Pain and Symptom Assessment Tool in Juvenile Fibromyalgia Syndrome

    Daniella Schocken1, Mark Connelly2, Sabrina Gmuca3, Andrea Ramirez4, Mary Ellen Riordan5, Tracy Ting6, Susmita Kashikar-Zuck7 and Jennifer Weiss8, 1Children's Mercy Kansas City, Tampa, FL, 2Children’s Mercy Kansas City/University of Missouri-Kansas City School of Medicine, Kansas City, MO, 3Children's Hospital of Philadelphia, Philadelphia, PA, 4Baylor College of Medicine, Houston, TX, 5Hackensack University Medical Center, Hackensack, NJ, 6Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7University of Cincinnati College of Medicine; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ

    Background/Purpose: Diagnosing juvenile fibromyalgia (JFM) in youth with chronic musculoskeletal (MSK) pain is challenging in the absence of a validated diagnostic tool. The Pain and…
  • Abstract Number: 2378 • ACR Convergence 2025

    Factors Associated With Fatigue In Systemic Lupus Erythematosus: Data From The Almenara Lupus Cohort

    Alvaro Oyarce-Calderón1, Rocío Gamboa-Cárdenas2, Victor Pimentel-Quiroz3, Samira Garcia-Hirsh4, Zoila Rodríguez-Bellido5, Cesar Pastor-Asurza6, Risto Perich-Campos7, Graciela Alarcón8 and Manuel Ugarte-Gil9, 1Hospital Nacional Guillermo Almenara Irigoyen, San Miguel, Lima, Peru, 2Universidad Científica del Sur, Lima, Peru, 3Universidad Científica del Sur, San Isidro, Peru, 4Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Pakistan, 7Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, La Molina, Peru, 8The University of Alabama at Birmingham, Oakland, CA, 9Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru; Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru, Lima, Peru

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by a wide spectrum of clinical manifestations, fatigue being one of them; it is…
  • Abstract Number: 1225 • ACR Convergence 2025

    Association between Anxiety and Tender Swollen Joint Difference in Patients with Rheumatoid Arthritis

    Clarice Lin1, Burcu Aydemir2, Jing Song3, Lutfiyya muhammad2, Clifton Bingham4, Tuhina Neogi5, Wendy Marder6, Marcy Bolster7, Daniel Clauw8, Dorothy Dunlop9 and Yvonne Lee1, 1Northwestern University, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University Feinberg School of Medicine, Worthington, MN, 4Johns Hopkins University, Baltimore, MD, 5Boston University School of Medicine, Boston, MA, 6University of Michigan, Ann Arbor, MI, 7Massachusetts General Hospital, Concord, MA, 8Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 9Northwestern University Feinberg School of Medicine, Chicago

    Background/Purpose: Some patients with rheumatoid arthritis (RA) have pain, despite normalization of inflammatory markers and reduced swollen joint counts. Among these patients, the number of…
  • Abstract Number: 2189 • ACR Convergence 2025

    Physician Practices and Perspectives in the Diagnosis and Management of Fibromyalgia: A US Chart Review Study

    Daniel Clauw1, Parul Houston2, Zhao Yang2, Todd Grinnell2 and Lesley Arnold3, 1Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Axsome Therapeutics, Inc, New York, NY, 3University of Cincinnati College of Medicine, Cincinnati, OH

    Background/Purpose: Fibromyalgia (FM) is a chronic, widespread pain disorder driven by dysregulated central pain processing, which impairs daily function and quality of life. Current understanding…
  • Abstract Number: 1224 • ACR Convergence 2025

    Comparative Effectiveness of Duloxetine versus Pregabalin in Fibromyalgia: A Large-Scale, Real-World Study Across 300,000 Patients

    Chukwuemelie Okeke1, Queeneth Edwards2, Ufuoma Mamoh3, Justin Riley Lam4 and Chekwubejah Uwakwe5, 1Maimonides Medical Center, Brooklyn, NY, 2Department of Epidemiology and Biostatistics, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA, 3Medstar Health Georgetown University Internal Medicine Residency Program, Baltimore, MD, 4Jefferson Einstein Hospital, Philadelphia, PA, 5Nnamdi Azikiwe University Teaching Hospital, Nigeria, Nnewi, Anambra, Nigeria

    Background/Purpose: Fibromyalgia (FM) is a chronic, debilitating condition characterized by widespread pain, fatigue, and cognitive disturbances. Despite the availability of FDA-approved treatments, real-world comparative effectiveness…
  • Abstract Number: 2098 • ACR Convergence 2025

    Responder Phenotype Analysis for Intra-Articular Injections: Secondary Analysis from a Large Multi-Site Crossover Clinical Trial

    Natalie Keller1, Bryant England2, Katherine Wysham3, Mercedes Quinones4, Marianna Olave5, Sarah Wetzel6, Hannah Brubeck7, Rachel Gillcrist6, Criswell Lavery8, Bibiana Ateh9, Bridget Kramer2, Kimberly Hayes6, Rui Xiao8, Kaitian Jin8, Alexis Ogdie8, Daniel K. White10, Tuhina Neogi11, Carla Scanzello12 and Joshua Baker8, 1University of Oklahoma, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4Howard University Hospital and Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, 5Brown University, Philadelphia, PA, 6Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 7VA Puget Sound Health Care System, Seattle, WA, 8University of Pennsylvania, Philadelphia, PA, 9Washington VA Medical Center, Washington, District of Columbia, 10University of Delaware, Newark, DE, 11Boston University School of Medicine, Boston, MA, 12University of Pennsylvania, Philadelphia

    Background/Purpose: Intra-articular (IA) corticosteroid injections are commonly utilized for pain management in knee osteoarthritis (KOA). However, clinical characteristics associated with a greater benefit from corticosteroid…
  • Abstract Number: 1221 • ACR Convergence 2025

    Oxytocin pathway gene BST1 polymorphism rs4273468 genotype GG is negatively associated with Fibromyalgia

    Zeeshan Ahmed1, Koshy Nithin Thomas2, Shivika Guleria3, Amita Aggarwal4 and Able Lawrence3, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 2Christian Medical College, Vellore, Tamil Nadu, India, 3SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

    Background/Purpose: Oxytocin, also known as love hormone, is important in contextual memory. Oxytocin secreting parvocellular neurons suppress pain through projections to brain and spinal cord…
  • Abstract Number: 0795 • ACR Convergence 2024

    Prevalence of Post-exertional Malaise (PEM) in Adults with Rheumatic Diseases and Relationship with COVID19 Infection

    Kaleb Michaud1, Shreena Kamlesh Gandhi2, Sofia Pedro3, Cassandra Calabrese4, Patti Katz5 and Leonard Calabrese6, 1University of Nebraska Medical Center, Omaha, NE, 2Kansas University School of Medicine - Wichita, Wichita, KS, 3Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 4Cleveland Clinic Foundation, Cleveland Heights, OH, 5UCSF, San Rafael, CA, 6Cleveland Clinic, Cleveland, OH

    Background/Purpose: Chronic fatigue is the dominant symptom in patients with Long COVID and Myalgic encephalomyelitis/Chronic fatigue syndrome (ME/CFS) as well as an important and prevalent…
  • Abstract Number: 1224 • ACR Convergence 2024

    Occupational Stress and Fibromyalgia Among Healthcare Professionals in Abu Dhabi Region, United Arab Emirates: A Cross-sectional Study

    Shamma Al Nokhatha1, Asma Alneyadi2, Noor Alnuaimi3, Hajar Almansoori3, Sara Alhosani3, Shammah Almemari4 and Muhammad Hashim3, 1Tawam hospital/ College of Medicine and Health Sciences, Al Ain, Abu Dhabi, United Arab Emirates, 2Tawam hospital, Al Ain, Abu Dhabi, United Arab Emirates, 3College of Medicine and Health Sciences, Al Ain, Abu Dhabi, United Arab Emirates, 4Ambulatory Health Services, Al Ain, Abu Dhabi, United Arab Emirates

    Background/Purpose: The stress level of healthcare workers may impact the quality of care provided to patients. The prevalence of occupational stress among healthcare workers can…
  • Abstract Number: 0796 • ACR Convergence 2024

    Development and Evaluation of Machine Learning Prediction Models for Hospitalizations Due to Opioid-Related Harms Among New Users with Rheumatic and Musculoskeletal Diseases

    Carlos Raul Ramirez Medina1, Mark Lunt2, David Jenkins2, William Dixon2, Niels Peek3 and Meghna Jani2, 1The University of Manchester, Warrington, United Kingdom, 2University of Manchester, Manchester, United Kingdom, 3THIS Institute , University of Cambridge, Cambridge, United Kingdom

    Background/Purpose: England has seen a notable rise in prescription opioid use over the past two decades, leading to some of Europe's highest opioid-related hospital admissions.…
  • Abstract Number: 1225 • ACR Convergence 2024

    Fibromyalgia as a Potential Initial Presentation for Autoimmune Conditions

    Qi Wang1, Pratibha Chaudhary2, Yu Chang3 and Megha Garg4, 1Unity Hospital/Rochester Regional Health, Rochester, NY, 2Rochester General Hospital, Rochester, NY, 3National Cheng Kung University Hospital, Tainan, Taiwan (Republic of China), 4Rochester Regional Health, Rochester, NY

    Background/Purpose: Fibromyalgia is a non-autoimmune disease with widespread pain, severe fatigue, and sleep problems. There are limited studies examining the association between fibromyalgia and autoimmune…
  • Abstract Number: 0797 • ACR Convergence 2024

    Associations Between Discordance of Disease Activity Indices and Quantitative Sensory Testing Measures of Nociplastic Pain in Patients with Early Rheumatoid Arthritis

    Clarice Lin1, Burcu Aydemir1, Jing Song2, Lutfiyya Muhammad3, Tuhina Neogi4, Wendy Marder5, Clifton Bingham6, Marcy Bolster7, Daniel Clauw8, Dorothy Dunlop9 and Yvonne Lee1, 1Northwestern University, Chicago, IL, 2Northwestern University, Worthington, MN, 3Northwestern Feinberg School of Medicine, Chicago, IL, 4Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 5University of Michigan, Ann Arbor, MI, 6Johns Hopkins University, Baltimore, MD, 7Massachusetts General Hospital, Boston, MA, 8University of Michigan, Whitmore Lake, MI, 9Northwestern University, New Haven, CT

    Background/Purpose: Approximately one-third of patients with rheumatoid arthritis (RA) experience nociplastic pain, a type of pain that occurs due to abnormalities in the way the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology